** Goldman Sachs ups Danish food ingredients maker Chr
Hansen CHRH.CO to "neutral" from "sell" as it believes the
market's has sufficiently downgraded its long-term expectations
** The broker sees upside to consensus on the back of the
group's recent acquisitions re-accelerating growth
** GS expects the stock to rerate thanks to the lower
interest rate environment and the group's quality growth during
the COVID-19 pandemic
** The broker sees EBIT margin at 29.3% in 2020 and 2021,
130 basis points above the higher end of the company's guidance
range
** One out 12 analysts is "buy" on the stock, seven "hold",
three "sell" and one "strong sell"
((marta.frackowiak@thomsonreuters.com))